From Genome to Therapy: Novartis Foundation Symposium 229

From Genome to Therapy: Novartis Foundation Symposium 229

Editor(s): Gregory R. Bock, Dalia Cohen, Jamie A. Goode

Published Online: 29 APR 2008

Print ISBN: 9780471627449

Online ISBN: 9780470846643

DOI: 10.1002/047084664X

Series Editor(s): Novartis Foundation

About this Book

This important and exciting work brings together a high-calibre group of experts to discuss the practical application of genomic information to the development of drugs. Recent technological advances have led to a rapid acceleration in our ability to gather genetic data. The complete genetic sequences are now known for several organisms and accelerated programmes are in place for sequencing many other genomes, including human. The speed with which complete sequencing can be accomplished will continue to increase as new technologies come online. In principle, the scope for developing new diagnostic techniques and drugs is now greater than at any time in human history, but the pathway from genetic information to usable drug is a long and complex one.

This major book covers such subjects as the current state of the art in squencing technology, the applications of these new technologies to sequencing the genomes of various organisms, and the challenge of proteomics. Additional contributions deal with legal and ethical implications of the new uses of genetic data, and functional genomics from the point of view of the pharmaceutical industry.

Table of contents

    1. You have free access to this content
    2. A Clinical Molecular Scanner to Study Human Proteome Complexity (pages 33–40)

      Denis Hochstrasser, Jean-Charles Sanchez, Pierre-Alain Binz, Willy Bienvenut and Ron D. Appel

    3. You have free access to this content